Thoracic Fluid Content During Hypervolemic Hemodilution
Pulmonary Edema
About this trial
This is an interventional diagnostic trial for Pulmonary Edema focused on measuring Thoracic fluid content, lung ultrasound, cesarean section, placenta accreta, colloid
Eligibility Criteria
Inclusion Criteria:
- female
- 18-45 years old
- ASA I-II
Exclusion Criteria:
- younger than 18 years,
- ASA > or = III
- patients with respiratory, cardiac disease, cardiac arrhythmias,
- body mass index above 40 kg/m2
- renal insufficiency,
- sepsis,
- hypovolemia denoted by PPV > 13 detected after start of mechanical ventilation,
- preoperative baseline LUS score 10 or more,
- TFC > or = 26 k ohm-1,
- patients with neck or chest lesions that impair the application of cardiometry electrodes
Sites / Locations
- Cairo University hospitals
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Control Group
The TFC Group
will receive a hypervolemic hemodilution with an IV infusion load of 6% HES.The infusion will be started preoperatively and will stop after completion of the infused volume. LUS evaluation will be done before start and after the end of the infusion.
will receive hypervolemic hemodilution with an IV infusion load of 6% HES.The infusion will be started preoperatively . The patient will be monitored for thoracic fluid content and LUS score. The infusion will stop if TFC reaches 40 k ohm-1 or after completion of the infused volume. LUS evaluation will be done before start and after the end of the infusion.